bromochloroacetic-acid has been researched along with Connective-Tissue-Diseases* in 6 studies
6 other study(ies) available for bromochloroacetic-acid and Connective-Tissue-Diseases
Article | Year |
---|---|
Epidermal cyst containing numerous spherules of keratin.
Topics: Back; Connective Tissue Diseases; Epidermal Cyst; Humans; Keratins; Male; Middle Aged | 2004 |
Antikeratin antibodies in sera of patients with connective tissue disease and liver disease.
Sera from 93 patients with connective tissue disease, 36 rheumatoid arthritis, 41 systemic lupus erythematosus, 12 polymyositis/dermatomyositis and 4 systemic sclerosis and sera from 12 patients with liver disease, along with sera of 10 healthy subjects, were tested for antikeratin antibodies using enzyme-linked immunosorbent assay in which the wells were coated with human epidermal keratin. Values above the mean+SD of the 10 healthy subjects were found in 8.3% of rheumatoid arthritis, 29.3% of systemic lupus erythematosus, 33.3% of polymyositis/dermatomyositis, 50% of systemic sclerosis, 16.7% of liver disease patients, and 20% of healthy subjects. The results indicated a character of naturally occurring antibody of antikeratin antibodies in human sera. Topics: Antibodies; Connective Tissue Diseases; Enzyme-Linked Immunosorbent Assay; Humans; Keratins; Liver Diseases | 2002 |
Familial elastosis perforans serpiginosa.
Elastosis perforans serpiginosa (EPS) is an uncommon skin disease characterized by transepidermal elimination of abnormal elastic fibers. The disease is frequently associated with congenital connective tissue disorders or Down's syndrome. The pathogenesis of EPS is still unclear. There are a few reports in the literature about a familial occurrence of EPS in which different modes of inheritance are suggested. To support the hypothesis of a congenital origin of the disease, we have studied another family with EPS.. In this study, we describe a family in which two sisters and a brother were affected by EPS. The father and three paternal uncles were most probably affected by the same disease. There were no signs of other congenital connective tissue disease in the family members.. An autosomal dominant mode of inheritance with variable expression of EPS is suggested. Topics: Adult; Aged; Atrophy; Cicatrix; Connective Tissue Diseases; Elastic Tissue; Elastin; Female; Humans; Keratins; Keratosis; Male; Middle Aged; Neck; Skin Diseases | 1993 |
[Anti-keratin antibodies: their significance in the diagnosis and prognosis of systemic connective tissue diseases].
Topics: Autoantibodies; Connective Tissue Diseases; Female; Humans; Keratins; Male; Prognosis | 1987 |
Anti-keratin antibodies in human sera: naturally occurring or induced?
Topics: Autoantibodies; Connective Tissue Diseases; Humans; Keratins; Male; Prostatic Diseases | 1987 |
Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases.
Tests for antikeratin antibodies (AKA) were performed on 2152 disease-associated and control sera by indirect immunofluorescence (IF) on rat oesophagus substrate. The incidence of AKA was significantly raised in rheumatoid arthritis (37%) in comparison with systemic sclerosis (8%), psoriasis (7%), ankylosing spondylitis (6%), systemic lupus erythematosus (3%), and normal controls (2%). AKA were detected in synovial fluid obtained from patients with rheumatoid arthritis (RA) (48%) but not from patients with other conditions. Further experiments on AKA-positive sera showed reactivity with stratum corneum of rabbit prepuce and lips. A specific rabbit antihuman keratin antiserum was shown, by IF and inhibition studies, to have a different specificity from that of spontaneous human AKA. AKA were associated with the presence of subcutaneous nodules in RA (p = 0.05), but not with Raynaud's phenomenon, Sjögren's syndrome, or HLA-DR4 positivity. Rheumatoid factor (RF) was not associated with AKA either in RA or in RF-positive disease controls. Topics: Antibody Specificity; Arthritis, Rheumatoid; Autoantibodies; Connective Tissue Diseases; Fluorescent Antibody Technique; Humans; Keratins; Raynaud Disease; Rheumatoid Nodule; Saliva; Sjogren's Syndrome; Synovial Fluid | 1985 |